Albert David

31
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE155C01010
  • NSEID: ALBERTDAVD
  • BSEID: 524075
INR
658.30
44.1 (7.18%)
BSENSE

Apr 02

BSE+NSE Vol: 7.59 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -4.61% vs 6.12% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -93.27% vs 5.66% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 26.70% vs -26.04% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -77.19% vs 108.49% in Mar 2024

Compare Profit and Loss Results of Albert David
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
345.00
368.00
-23.00
-6.25%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
34.00
-34.00
-100.00%
Net Sales
345.00
333.00
12.00
3.60%
Expenditure (Ex Depriciation)
Stock Adjustments
-14.00
4.00
-18.00
-450.00%
Raw Materials Consumed
130.00
164.00
-34.00
-20.73%
Power & Fuel Cost
14.00
27.00
-13.00
-48.15%
Employee Cost
109.00
45.00
64.00
142.22%
Operating Expenses
9.00
28.00
-19.00
-67.86%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
36.00
4.00
32.00
800.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
18.00
7.00
11.00
157.14%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
342.00
289.00
53.00
18.34%
Operating Profit (PBDIT) excl Other Income
3.00
44.00
-41.00
-93.18%
Other Income
29.00
3.00
26.00
866.67%
Operating Profit (PBDIT)
32.00
48.00
-16.00
-33.33%
Interest
0.00
7.00
-7.00
-100.00%
Profit before Depriciation and Tax
32.00
40.00
-8.00
-20.00%
Depreciation
6.00
10.00
-4.00
-40.00%
Profit Before Taxation & Exceptional Items
25.00
30.00
-5.00
-16.67%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
25.00
30.00
-5.00
-16.67%
Provision for Tax
8.00
8.00
0.00
0.00%
Profit After Tax
17.00
21.00
-4.00
-19.05%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
238.00
101.00
137.00
135.64%
Profit Available for appropriations
255.00
122.00
133.00
109.02%
Appropriations
255.00
122.00
133.00
109.02%
Equity Dividend (%)
50%
15%
35.00
Earnings Per Share
30.14
70.69
-40.55
-57.36%
Profit And Loss - Net Sales
Net Sales 345.77 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -4.61% vs 6.12% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.16 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -93.27% vs 5.66% in Mar 2024

Profit And Loss - Interest
Interest 0.55 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 26.70% vs -26.04% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 17.20 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -77.19% vs 108.49% in Mar 2024